CVS Health (NYSE: CVS) reported third-quarter 2020 financial results before the market hours on Friday. The retail pharmacy reported a 4% growth in Q3 revenue to $67.1 billion, surpassing the Wall Street consensus. The company reported a net income of $1.66 per share, better than the estimates set by analysts.
CVS shares rose 3.2% immediately following the announcement. The stock has fallen 17% since the beginning of this year.
CEO Larry Merlo said, “We’ve opened more than 4,000 COVID-19 test sites across the country since March, and have administered over six million tests. We’re helping businesses and universities safely reopen and we were recently selected to administer COVID-19 vaccinations in long-term care facilities.”
Prior performance
Most Popular
QCOM Earnings: Qualcomm Q2 2024 revenue and profit beat Street view
Semiconductor company Qualcomm, Inc. (NASDAQ: QCOM) reported an increase in earnings and revenues for the second quarter of 2024. The numbers came in above analysts' estimates. At $9.39 billion, March-quarter
Key takeaways from Amazon’s Q1 2024 earnings report
Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months of the year. While the cloud segment continues
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top and bottom line numbers decreased